Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

BACKGROUND/PURPOSE: Spasticity is one of the most common symptoms in people with multiple sclerosis (MS). Conventional anti-spasticity agents have limitations in their efficacy and tolerability. Delta-9-tetrahydrocannabinol: cannabidiol (THC:CBD) spray, a cannabinoid-based medicine, is approved as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Akgün, Katja, Essner, Ute, Seydel, Cordula, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413425/
https://www.ncbi.nlm.nih.gov/pubmed/30886530
http://dx.doi.org/10.1177/1179573519831997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413425/
https://www.ncbi.nlm.nih.gov/pubmed/30886530
http://dx.doi.org/10.1177/1179573519831997

Ejemplares similares